Deutsche Bank
CTKB icon

Deutsche Bank’s Cytek Biosciences CTKB Stock Holding History

Deutsche Bank’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$583K Sell
97,882
-14,050
-13% -$66.6K ﹤0.01% 2542
2026
Q2 		$496K Buy
111,932
+7,495
+7% +$32K ﹤0.01% 2779
2026
Q1 		$456K Buy
104,437
+11,298
+12% +$53.3K ﹤0.01% 2617
2025
Q4 		$470K Buy
93,139
+4,119
+5% +$19.1K ﹤0.01% 2606
2025
Q3 		$309K Buy
89,020
+11,972
+16% +$44.9K ﹤0.01% 2830
2025
Q2 		$262K Sell
77,048
-16,906
-18% -$56.3K ﹤0.01% 2816
2025
Q1 		$377K Sell
93,954
-9,228
-9% -$47.8K ﹤0.01% 2632
2024
Q4 		$670K Buy
103,182
+36,542
+55% +$218K ﹤0.01% 2468
2024
Q3 		$369K Buy
66,640
+9,725
+17% +$55.1K ﹤0.01% 2625
2024
Q2 		$318K Sell
56,915
-10,241
-15% -$61.5K ﹤0.01% 2568
2024
Q1 		$451K Buy
67,156
+1,552
+2% +$12.3K ﹤0.01% 2408
2023
Q4 		$598K Sell
65,604
-1,258
-2% -$7.92K ﹤0.01% 2289
2023
Q3 		$369K Buy
66,862
+15,811
+31% +$127K ﹤0.01% 2366
2023
Q2 		$436K Sell
51,051
-24,043
-32% -$216K ﹤0.01% 2435
2023
Q1 		$690K Buy
75,094
+18,637
+33% +$200K ﹤0.01% 2309
2022
Q4 		$576K Buy
56,457
+4,790
+9% +$64.4K ﹤0.01% 2364
2022
Q3 		$761K Sell
51,667
-5,725
-10% -$74.4K ﹤0.01% 2141
2022
Q2 		$616K Buy
57,392
+2,808
+5% +$27.9K ﹤0.01% 2471
2022
Q1 		$588K Buy
54,584
+44,165
+424% +$596K ﹤0.01% 2650
2021
Q4 		$170K Buy
10,419
+543
+5% +$11.4K ﹤0.01% 3456
2021
Q3 		$212K Buy
+9,876
New +$232K ﹤0.01% 3538

Other funds holding CTKB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Deutsche Bank's CTKB Position: Q3 2026 in Review

Deutsche Bank reduced its Cytek Biosciences (CTKB) stake by 13% in Q3 2026, selling an estimated $66.6K and leaving 97,882 shares worth $583K. The position accounts for ﹤0.01% of the portfolio, ranked #2542.

Deutsche Bank first reported a position in CTKB in Q3 2021 and has held it in 21 quarters since. The position peaked at $761K in Q3 2022. 48 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.

  • Deutsche Bank held 97,882 shares of Cytek Biosciences worth $583K as of Q3 2026.
  • Deutsche Bank sold 14,050 Cytek Biosciences shares in Q3 2026, an estimated $66.6K.
  • Cytek Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2542 holding.
  • Deutsche Bank first reported a position in Cytek Biosciences in Q3 2021 and has held it in 21 quarters since.
  • Deutsche Bank's Cytek Biosciences position peaked at $761K in Q3 2022.
  • 48 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.